SABIMED
ActiveSummary
SABIMED has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €406,281 and a net result of €283,502. Its solvency ranks better than 69% of 20,511 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
30-01
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
30-06
Financial
Equity above €200,000equity €406,281 ▲231%
A profit in every financial year since 2024 builds equity to €406,281.
03-02
NBB filing
Annual accounts filed
financial year 2024 · micro format · 3 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.